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Abstract
Abstract STUDY QUESTION How can the decision process for fertility
preservation (FP) in adolescents and prepubertal boys be improved based
on patient and parent feelings about FP counseling? SUMMARY ANSWER
The content of information given to patients and parents and hope for future
parenthood appeared to positively impact on the decision to preserve fertility in
the pediatric population and, therefore, deserves special attention to improve FP
care. WHAT IS KNOWN ALREADY A vast body of literature on adult cancer
patients shows that reproductive capacity is a major quality-of-life issue. Patients
also have a strong desire to be informed of available FP options with a view
to future parenthood of their own genetic child, considering that <10% chose to
adopt or used donated gametes. Furthermore, the quality of fertility counseling
provided at the time of cancer diagnosis has been identified as a crucial factor in
the decision-making process. By contrast, in the pediatric population, whil...
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studyquestion: How can the decision process for fertility preservation (FP) in adolescents and prepubertal boys be improved based on
patient and parent feelings about FP counseling?
summaryanswer: Thecontentof informationgiven topatientsandparents andhope for futureparenthoodappeared topositively impact
on the decision to preserve fertility in the pediatric population and, therefore, deserves special attention to improve FP care.
what is known already: Avast body of literature on adult cancer patients shows that reproductive capacity is a major quality-of-life
issue. Patients also have a strong desire to be informed of available FP options with a view to future parenthood of their own genetic child,
considering that ,10% chose to adopt or used donated gametes. Furthermore, the quality of fertility counseling provided at the time of
cancer diagnosis has been identiﬁed as a crucial factor in the decision-making process. By contrast, in the pediatric population, while it was
shown that parents were able to make an informed and voluntary decision for their prepubertal sons despite the heavy emotional burden at
the timeof diagnosis, there is so far very limited informationonpatient expectations regarding FP.A lackof awareness often equates to suboptimal
care by oncologists and FP specialists, and poor access to FP, therefore improving knowledge and identifying the expectations of pediatric patients
and their parents are crucial for optimizingmultidisciplinary collaborative care pathways (MCCPs), including counseling and access to FPmethods,
in the youngest population.
study design, size, duration: A questionnaire survey was posted to an eligible population between May 2005 and May 2013.
participants/materials, setting, methods: A total of 348 prepubertal boys and adolescents aged 0–18 years, diagnosed
with cancer in a university hospital setting,were eligible. Threedifferent questionnaires for two age groups of children (,12 and12–18 years) and
parentswereestablishedbasedon information from focus groups.Questionswere subsequently reviewedby the institutional ethics boardbefore
being sent.
main results and the role of chance: Of the 348 eligible patients, 44 died and 14 were lost to follow-up. Thus, 290 patients
(77 aged 12–18 years and 213 aged,12 years)were sent a questionnaire. In total, 120 questionnaireswere recovered, 45.5% (n ¼ 35/77) from
adolescents and 39.9% (n ¼ 85/213) from children. FP acceptance rates were, respectively, 74 and 78.6% for boys aged,12 and 12–18 years.
The content of information provided to patients and parents appeared to positively impact on the decision to preserve fertility (P ¼ 0.04).While
the majority of boys aged .12 years considered the information to be clear (72%), complete (80%) and understandable (90.9%), only 33.3%
of boys aged ,12 years were able to comprehend the information. Pressure from doctors to reduce the delay between diagnosis and cancer
treatment increased the number of refusals (P,0.01), while hope for future parenthood favored acceptance (P, 0.01). Family support was
considered important for 75% of adolescents and 58% of children, and medical support for 50% of adolescents and 42% of children.
limitations, reason for caution: This single-center survey does not allow extrapolation of the information to other settings.
Recall bias and lack of full external validation of the questionnaires are further limitations. Modiﬁcation of the current MCCP should be further
evaluated according to our results.
& The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
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wider implications of the findings: Acknowledging the issues faced and familiarizing oneself with the care of patients
undergoing fertility-threatening therapies supply primary care providers with the appropriate quality management tools in the ﬁeld of
FP in centers for reproductive medicine. Expectations reported in the survey allow appropriate support to be included within the
MCCP design.
study funding/competing interest(s): Funding by hospital/clinic(s); CliniquesUniversitaires Saint Luc, Brussels, Belgium.
The authors have no conﬂict of interest to declare.
trial registration number: NCT02411214.
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Introduction
Improvements in cancer therapy and extension of gonadotoxic therapy
to benign conditions mean that there is now a steadily growing popula-
tion of young people affected by reproductive issues after successful
fertility-threatening therapies. Cryopreservation of mature sperm col-
lected by masturbation with or without assisted ejaculation techniques
orbyepididymalor testicular tissue sampling (Wyns, 2013) is increasingly
being proposed to adolescents, having been routinely applied in adults
for many years now (Lass et al., 1999).
However, for prepubertal boys, the only option for fertility preserva-
tion (FP) is cryopreservation of immature testicular tissue (ITT) (Keros
et al., 2007; Wyns et al., 2008; Curaba et al., 2011; Poels et al., 2013)
with a view to future autografting or in vitromaturation of spermatogonial
stem cells (for review, see Wyns et al., 2010). While human ITT
cryopreservation is still at an experimental stage, research related
to fertility restoration strategies using cryopreserved ITT is actively
ongoing, showing promising results with respect to clinical application
(Hermann et al., 2012). This raises speciﬁc issues of practice, information
provision to patients, their parents and professionals, and speciﬁc ethical
issues of consent. More precisely, such ethical issues concern the ability
of children to consent to both treatment and preventive measures, such
as gamete storage, where understanding, the key to this process, may
not be such that they are legally competent. Even more complex is the
scenario where children and parents’ autonomy clash, the child refusing
what the medical team and parents feel is both the most beneﬁcial and
the least harmful approach in the proposed care (Miller et al., 2004).
Providing patientswith themost effective treatmentsmeans that infer-
tility issues often take second place for most oncologists (Bradlyn et al.,
2004). Consequently, when they begin therapy, most young patients
are not informed of the risk of fertility impairment or loss (Schover
et al., 2002a; Zebrack et al., 2004). While rates at which adult patients
are informed of potential infertility steadily improve with increasing
oncologists’ awareness of the importance of FP issues (Quinn et al.,
2009 ; Adams et al., 2013; Buske et al., 2015), there is still a long way
to go in the pediatric population. Indeed, it was shown that only 46%
of pediatric oncologists refer theirmale pubertal cancer patients to a fer-
tility specialist (Ko¨hler et al., 2011). Furthermore, the emergency context
and lack of time in the case of cancer, insufﬁcient knowledge of care
providers regarding FP options and patient and parent expectations,
apprehension about patients’ receptiveness to discussing FP, and the
availability of FP resources constitute other barriers to talking about
fertility issues (Goodwin et al., 2007; Vadaparampil et al., 2008). More-
over, the patient’s health before treatment and the disease prognosis
may inﬂuence care providers not to push FP at such a sensitive time
(Achille et al., 2006; Gilbert et al., 2011) or consider delaying treatment
because of the aggressiveness of the disease (Reebals et al., 2006).
As a result, sperm banking rates are disappointingly low, reported to
be only 18–28%of affected adolescents (Klosky et al., 2009;Nagel et al.,
2009), although deﬁning appropriate clinical pathways for FP has
improved referrals (Anderson et al., 2008). For prepubertal boys,
however, because ITT cryopreservation is new and not yet widespread,
corresponding ﬁgures are not available. Reported clinical experience is
also scarce (Wyns et al., 2011) or limited to small pilot studies (Ginsberg
et al., 2010), even if spermatogonial stem cell cryopreservation by tes-
ticular sampling appears to be just as acceptable ‘to parents’ as freezing
of a semen sample collected by masturbation or assisted ejaculation
(Van den Berg et al., 2007).
Besides the strong desire of patients to be informed of available FP
options, reproductive capacity has emerged as a major quality-of-life
issue among survivors, and even a slight chance of infertility is considered
a major burden. Indeed, it was found that loss of fertility is often per-
ceived as loss of masculinity (Schover et al., 1999; Eiser et al., 2011). In
addition, for the majority of cancer survivors, their illness increases the
value they place on parenthood and family (Schover, 2005), and
,10% chose to adopt or used donated gametes (Schover et al., 1999;
Schover et al., 2002a).
FP measures must, therefore, be given greater priority. This is even
more challenging in the pediatric population, where children are asked
to consider parenthood when they do not generally contemplate this
matter and to project themselves to some distant point in the future,
and where joint decisions between parents and children need to be
reached during the acute phase of the disease.
The quality of fertility counseling provided at the time of cancer diag-
nosis hasbeen identiﬁed as acrucial factor in thedecision-makingprocess
(Schover et al., 2002a; Achille et al., 2006). However, very few papers
discuss decisions on FP in the pediatric population. Three pilot studies
assessed parental acceptance of FP strategies in adolescents (Sadri-
Ardekani et al., 2013) and prepubertal boys (Van den Berg et al., 2007;
Ginsberg et al., 2010; Sadri-Ardekani et al., 2013), but two (Van den
Berg et al., 2007; Sadri-Ardekani et al., 2013) used retrospective scen-
arios with hypothetical access to the technique in the future because
of its unavailability at the time. One more recent preliminary study of
interest evaluated the decisional process of parents of 48 prepubertal
boys undergoing ITT cryopreservation, within the context of a research
protocol investigating a speciﬁc population at high risk of infertility
(Ginsberg et al., 2014).While this study analysed parent decision-making
inﬂuences and perceived levels of personal decision-making control and
mood states, neither the child’s attitudes or emotional states related to
FP acceptance and implementation nor the importance placed on
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medical staff and family support during the decisional process was
addressed. Moreover, children who could beneﬁt from ITT cryopreser-
vationwere considered tobe tooyoung tobe surveyed (Ruutiainen et al.,
2013). Our experience with ITT cryopreservation since its implementa-
tion in our department has allowed us to gather information about
children’s feelings toward this FP method.
In the absence of clear information about such patients’ expectations,
clinicians are often left to make decisions based on assumptions about
their patients’ or parents’ wishes regarding future fertility and FP, and
on their own moral codes.
The aim of this article is, therefore, to critically analyse the multidiscip-
linary collaborative care pathway (MCCP) in the pediatric population, fo-
cusingon factors inﬂuencing thedecision, and toelucidateandcharacterize
the feelingsof patients and their parents,with a view tobetter fulﬁlling their
expectations. To our knowledge, this is the largest study evaluating FP in
prepubertal boys in whom testicular biopsy for spermatogonial stem cell
preservation was a real option. Ethical considerations related to FP in
the pediatric population have also been addressed.
Materials andMethods
Patient recruitment and questionnaires
A total of 348 prepubertal boys and adolescents aged 0–18 years diagnosed
with cancer between May 2005 and May 2013 were eligible for this study.
Three different questionnaires, for children (,12 and 12–18 years) and
parents,were prepared basedon information gathered from focus groupdis-
cussions with patients and parents, and the scientiﬁc literature. Interviews
with families conducted by a nurse from the pediatric hematology–oncology
department also aimed at controlling for use of unfamiliar terminology and
appropriateness of questions, as well as uncovering issues that the medical
team would not have considered. Survey questionnaires used mainly
closed-ended questions followed by response options to minimize random
errors in the data collection process and allow quantitative interpretation.
The proposed answers were deﬁned based on the experience of the
survey developers and the study hypothesis set by them, which could be
seen as ‘leading’ questions/answers. Nevertheless, we left the possibility
to add spontaneous answers in free text boxes allowing further communica-
tion of patient and parent feelings or thoughts on the situation. Items and
related questions were subsequently reviewed by the oncologic, reproduct-
ive and liaison psychiatrymedical teams for content validity, beforebeing ana-
lysed and approved by the institutional ethics board, and sent by regular mail
to the parents. Two reminderswere also sentwith the right to decline to par-
ticipate during the survey period from June 2013 to October 2013. Consist-
ency of response was evaluated on a population sample at a randomly
scheduled follow-up consultation.
The questionnaires comprised two parts. Part 1 included sociocultural
population characteristics, type of disease and questions about information
receivedbypatients andparents. Part 2 focusedoncommunication (informa-
tion content, time of information transfer, information provider), emotional
state and perceptions during discussion of FP, reasons for refusal, parental
views on the involvement of their children in the decisional process, as well
as the importance of medical/paramedical and family supports.
The difference between parent and patient questionnaires was the
wording, which was simpliﬁed to facilitate understanding for children. For
adolescents, an additional question about the method of sperm collection
for FP was included.
For childrenwhowere too young to answer the survey themselves, paren-
tal help was sought, and for those who were too young to participate in the
survey (below the age of 5 years at diagnosis), only answers from parents
were obtained.
The study was performed at Cliniques Universitaires Saint Luc, a Belgian
university setting, and approvedby the institutional reviewboardof theCath-
olic University of Louvain. Hence, from 2005 on, all children subjected to
fertility-threatening therapies could undergo ITT cryopreservation if their
parents (and child if applicable) were informed about the experimental
nature of themethod and lack of currently available fertility restoration tech-
niques (see next paragraph for consent issues), according to the Belgian law
on human experimentation (Moniteur Belge, Loi relative aux experimenta-
tions sur la personne humaine, 7th May 2004), which sets out the consent
process, need for ethics committee approval and speciﬁc issues related to
the protection of minors. Because no children have yet been born as a
result of the ITT technique and, hence, its efﬁcacy cannot be established, it
is not covered by national insurance and was not paid for by the patient.
MCCP for patients at risk of infertility
Information on FP was initially given to parents and patients by pediatricians
and oncologists, who referred the case to one of two reproductivemedicine
specialists. All patients/parents could have access to a method of FP before
initiation of cancer therapy. Rapid and ﬂexible access tomedical consultation
with a reproductive medicine specialist, and to facilities for sperm or tissue
sampling that could accommodate acutely ill young patients before they
undergo gonadotoxic therapies, was provided. From the age of 5 years and
provided his health permitted, the child’s presencewas strongly encouraged
during this consultation. The fertility specialist then assessed the potential
testicular content based on physical examination and previous history, and
investigated the possibility of obtaining an ejaculate by masturbation or
penile vibratory stimulation (for boysclose to12 yearsorolder).Appropriate
case-by-case information on sexual maturation, including pubertal events,
testicular maturation with potential content linked to age, sperm emission,
reproduction, as well as semen or testicular tissue cryopreservation and
storage, was given. The language was adapted to the child’s age. In the
course of the consultation, boys and their parents were encouraged to ask
questions freely. From the age of 12 years, the patient was invited to
discuss FP without his parents being present. For peripubertal boys who
were candidates for semen sampling, a trainednurse or laboratory technician
from the unit of reproductive medicine also explained the procedure of
sperm collection and assisted the patient in the absence of his parents at
the laboratory facilities. For prepubertal boys, information on tissue sampling
was provided as previously reported (Wyns et al., 2011), and potential fertil-
ity restoration approaches from testicular biopsies were explained to each
individual child and his parents, making sure they understood that there is
no guarantee of success with stored ITT as yet and that it therefore must
be considered experimental. In all cases, parents or legal guardians gave
their consent for cryobanking in writing, and the child’s assent was sought
if he was mature enough to understand the implications of the procedure.
Parents of minors were advised to have a consultation at their majority to
conﬁrm earlier decisions and to receive information on the evolution of
fertility restoration techniques.
Becauseof the high volumeof information exchanged during such a consult-
ation, adolescent patients were invited at least 1 year after the end of cancer
treatment for fertilitymonitoring and discussion about the subsequent dispos-
ition of stored samples. Prepubertal patients were asked to return any time
after completing cancer therapy, but in any case at the age of 18 years to
discuss scientiﬁc progress on ITT banking and sample disposition.
Statistics
Proportions were compared using the chi-square test or Fisher’s exact test.
NCSS statistical system 2007 (Kaysville, Utah 84037) was used. Bilateral
testingwasapplied.AP valueof,0.05wasconsidered statistically signiﬁcant.
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Results
Population characteristics and response rate
Of the 348 eligible patients, 44 patients died and 14 were lost to follow-
up. Thus, 290 patients (77 aged 12–18 years and 213 aged ,12 years)
and their parents were sent questionnaires. Among them, 96 (33.1%)
responded to the ﬁrst mailing and 8 declined to participate in the
survey. After three reminders, a total of 120 questionnaires were recov-
ered from parents (with or without the corresponding questionnaire
from their child), yielding an overall response rate of 41.4%, including
45.5% from adolescents (n ¼ 35/77) and 39.9% from children (n ¼
85/213). For these 120 questionnaires and a further 51 recovered
from children out of a total population of 290 parents and 290 children,
we obtained a margin of error of 7 and 12% for parents and patients,
respectively, (conﬁdence level ¼ 95%). Response rates by the type of
pathology are presented in Table I.
Median age at diagnosis was 6.05+ 3.74 years (range 0.1–143
months) and 14.41+1.5 years (range 144–212 months) for boys
aged ,12 and 12–18 years, respectively. Mean (+SD) follow-up
from diagnosis to the time of the survey was 3.4+2.3 years.
Since42patients (35%)didnot receive informationonFP issues,only78
questionnaires includedresponses toPart2.Among these42patientswho
did not have exposure to a FP discussion, we recorded patients who did
not require chemotherapy (16), very young patients [,2 years of age
(11)], patients who received previous chemotherapy (1), very high emer-
gency for starting chemotherapy (2), trisomy 21 (1 patient) and unknown
reason (11). Patient perceptions of FP could be recorded fromthe age of 9
years (at diagnosis). Indeed, 39.3% of children aged ,12 years did not
answer thesequestions comparedwithonly8%ofboys aged12–18years.
Response by patients, parents or both
No questionnaires were received from children without the completed
questionnaire from their parents. In addition to the 120 answers from
parents who did not decline to participate, 28 patients under 12 years
of age and 23 aged 12–18 years answered the questionnaire with or
without parental help, the youngest patient being just 5 years old at the
time of diagnosis.
For 22 patients under 12 years of age and 3 aged 12–18 years, only
answers from parents were obtained. Parents considered their child
capable of understanding and participating in the decisional process in
91.4% of adolescents (versus 26.2% of children aged ,12 years).
FPacceptance rateswere74 and78.6% for boys aged,12and12–18
years, respectively. Acceptance by disease is shown in Table II.
No discrepancy between patient and parent decisions was noted,
indicating that decisions were essentially made jointly.
Six adolescents and 13 children under the age of 12 years refused
to undergo FP procedures, corresponding to, respectively, 7.7 and
16.7% of the total population of responders. Reasons for refusal were
the urgency of cancer treatment, diminished general health, the FP pro-
cedure not being a priority or the experimental status of FP before
puberty. Wishing to avoid an additional procedure was not an issue for
FP acceptance.
Population sociocultural characteristics
Population sociocultural characteristics were analysed and correlated
with FP acceptance (Table III). The age of patients was not found to be
a relevant factor in the acceptance of FP (P ¼ 0.79), and the same was
true for nationality, religion and parental employment.
........................................................................................
Table I Pathology and response rate in amale pediatric
population.
Cancer type N N deceased Response rate
Acute lymphoblastic
leukemia
67 7 55% (33/60)
Acute myeloid leukemia 15 2 15.4% (2/13)
Non-Hodgkin’s lymphoma 34 6 46.4% (13/28)
Hodgkin’s lymphoma 15 40% (6/15)
Medulloblastoma 15 3 25% (3/12)
Nephroblastoma 15 26.7% (4/15)
Neuroblastoma 30 6 37.5% (9/24)
Osteosarcoma 34 6 32.1% (9/28)
Retinoblastoma 46 15.2% (7/46)
Ewing’s sarcoma 10 2 75% (6/8)
Rhabdomyosarcoma 13 2 54.5% (6/11)
Hepatoblastoma 10 2 50% (4/8)
Brain tumor 24 6 38.9% (7/18)
Astrocytosis 5 40% (2/5)
Ependymoma 3 33% (1/3)
Benign pathologies 12 2 70% (7/10)
TOTAL 348 44 39.1% (119/304)
........................................................................................
Table II FP acceptance by disease in a male pediatric
population.
Pathology Sample
stored, n
Sample not
stored, n
ALL 21 12
AML 0 2
Osteosarcoma 7 2
Brain tumor 3 4
Non-Hodgkin’s lymphoma 6 7
Hodgkin’s lymphoma 5 1
Neuroblastoma 3 6
Rhabdomyosarcoma 5 1
Nephroblastoma 0 4
Hepatoblastoma 2 2
Medulloblastoma 1 2
Retinoblastoma 0 7
Testicular cancer 1 0
Sarcoma 5 1
Astrocytoma 0 2
Ependymoma 0 1
Benign pathology 0 7
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia.
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Communication issues
Only 78 questionnaires included responses to Part 2. Information
content, timing and provider are described in Table IV. The complete-
ness of information provided to patients and parents appeared to
positively impact on the decision to preserve fertility (P ¼ 0.04).
For boys over 12 years of age, 91.4% of parents considered their child
capable of participating in the decision process (versus 26.2% for those
under 12 years, with the youngest being 7 years old). For the rest, not
only immaturity of the child (5.7%) but also poor general health (2.9%)
explained their inability to do so.
Emotional state of parents and children
during FP explanations
For the parents, this is summarized in Table V. Pressure from doctors
to reduce the delay before cancer treatment increased the number of
refusals (P, 0.01), while hope for future parenthood favored accept-
ance (P, 0.01).
With regard to the patients, 52% of adolescents felt anxious at the
time of discussion versus 23.5% of children. The main reason was
their concern about future fertility, rather than the method of FP.
Nevertheless, 46% of boys aged 12–18 years considered the FP
method challenging because of poor general health, lack of experience
with masturbation and its taboo or embarrassing nature.
Seventy-six percent of children considered their health to be more
important than the ability to have a family (compared with 48% of
adolescents).
Finally, family was considered important for 75% of adolescents and
58% of children, and medical support was considered important for
50% of adolescents and 42% of children. Nursing support was relevant
for 16.6% of adolescents.
Information understanding
While the majority of boys aged .12 years considered the information
to be clear (72%), complete (80%) and understandable (90.9%), only
33.3% of boys aged ,12 years were able to comprehend the informa-
tion, the youngest being 11 years old (although, respectively, 71.4 and
57.9% of subjects found it to be complete and clear).
Discussion
While survival studies document the struggles of having children after
cancer treatment, concerns of children and their parents about future
fertility at the time of diagnosis and factors inﬂuencing the FP decision-
making process are not well documented, especially in the pediatric
population. It was reported that families of children affected by cancer
do indeed have concerns about fertility-related side effects of their
treatment (Oosterhuis et al., 2008) and want to be presented with
options (Van den Berg et al., 2007), but the literature also shows a gap
between the medical team’s awareness of the need to address FP
issues and taking action when the opportunity arises. Indeed, while
........................................................................................
Table III Population characteristics and acceptance
of FP.
FP refused,
n (%)
FPaccepted,
n (%)
P-value
Age of male patients
,12 years 13 (26%) 37 0.79
12–18 years 6 (27.3%) 22
Nationality
Belgian* 14 (73.7%) 52 (88.1%) 0.15*
European
(non-Belgian)*
5 6
Other 0 1
Religion
Catholic* 13 (72.2%) 37 (62.7%) 0.35*
Muslim 2 2
Protestant 0 2
Jewish 0 1
Atheist 0 5
Other 2 10
No answer 1 2
Employment of parents
Employee* 14 (73.7%) 50 (84.7%) 0.31*
Manual worker 3 4
Civil servant 0 1
Retired 0 1
Without employment 1 2
No answer 1 1
Data are from n ¼ 78 questionnaires.
A comparison was made between accepted or refused FP. The chi-square test was
applied for comparisons between Belgian and European*,Catholic and non-Catholic*,
and employee and non-employee*.
........................................................................................
Table IV Communication of FP information.
FP refused
(n)
FP accepted
(n)
P-value
Information content (completeness)
Satisfactory 12 51 0.04
Not satisfactory 7 8
Timing of FP information
At diagnosis* 6 15 0.77*
A few days after
diagnosis
4 17
When explaining
cancer treatment
7 23
At ﬁrst chemotherapy
session
2 4
Information provider
GP or pediatrician 2 5 ND
Oncologist 15 49
Specialist 2 3
Nurse 0 2
Data are from n ¼ 78 questionnaires.
A comparison was made between accepted or refused FP. The chi-square test was
applied for information content (satisfactoryor not). Fisher’s exact testwas applied for
the timing of FP information (*at diagnosis or at any other time).
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91% of practitioners felt that sperm banking should be mentioned to
patients whose treatment could impair fertility, 48% never mentioned it
or informed less than a quarter of their patients (Schover et al., 2002b).
Paucity of training for clinicians and lack of information for patients were
also identiﬁed as contributing factors (Gilbert et al., 2011). This has been
recently reﬂected in survey data, which showed that patients had poor
knowledge of FP options (22% of pediatric patients), with only 15% ad-
equately informed before the start of therapy (Sadri-Ardekani et al.,
2013). In our study, despite a well-established multidisciplinary collabora-
tive approachbetweenoncologists and reproductive physicians, one-third
of thepatientswere still lacking informationabout FPoptionswhen seenby
the oncologist. Insufﬁcient or inappropriate knowledge and training of
cancer care providers most probably play a key role in such poor ﬁgures.
Although deﬁning a FP pathway represents an important step in the
management of patients facing fertility-threatening therapies, further
optimization is required.
The decision-making process is highly complex in the pediatric popu-
lation.On theone hand, childrenmay lack the capacity to understand the
implications of FP. On the other hand, parents are forced to consider
their child’s potential wish to have children in the future, while faced
with the life-threatening nature of the disease, which may reduce their
competence in decision-making (Grundy et al., 2001) at an already
stressful time. This is even more critical when FP requires an additional
surgical procedure that may be regarded experimental on account of
its unknown potential for fertility restoration.
Because of the highly emotional state of those affected by such a
serious diagnosis, awareness of feelings and expectations of patients
and parents and knowledge of factors inﬂuencing FP acceptance are of
upmost importance.
Acceptance of FP in the pediatric population appears to be linked to
the way the subject is introduced, with acceptance rates in prepubertal
boys ranging between 54 and 76% (Van den Berg et al., 2007; Ginsberg
et al., 2010; Sadri-Ardekani et al., 2013). The highest rate was obtained
with face-to-face consultation at the time of cancer diagnosis in a small
pilot study that included 21 patients for whom ITT sampling was a real
option (Ginsberg et al., 2010), which is in accordance with our larger
series (74 and 78.6% for boys aged,12 and 12–18 years, respectively).
Our survey did not reveal the child’s age to be an issue for FP accept-
ance. However, patients’ perceptions were different in the two age
groups, with the vast majority of adolescents considering themselves
to be fully and clearly informed and able to understand the information,
comparedwith onlyone-third of boys aged,12 years.While the reason
for this difference seems obvious for the youngest patients, further ana-
lysis of the inﬂuence of perception on FP acceptance was not possible.
Indeed, for minors, even when it was possible to obtain the patient’s
assent, parents remained the ﬁnal decision-makers (Bahadur et al.,
2000, 2001; Robertson, 2005).
It is interesting to note that parents made joint decisions with their
adolescent sons. The way of conducting discussions was also found to
play a possible role, but the literature shows conﬂicting results on
patient and parent involvement in the decision-making process. On
the one hand, up to almost half of patients preferred to have initial dis-
cussions without their parents being present; but on the other hand,
theywerepleasedwith their parents’ involvement in thedecision-making
process (Crawshawand Sloper, 2006). In our setting, patientswere seen
jointly with their parents, and the discussion was conducted with the
aim of securing a joint decision on FP acceptance, respecting the child’s
best interests (Shenﬁeld et al., 2002). In this regard, it has indeed been
suggested that preserving fertility protects patient’s choice as adults
(Glaser et al., 2004). Setting aside dedicated time for discussion with
peri- and postpubertal patients in the absence of their parents could
also explain why we did not ﬁnd the patient’s age to be an issue,
despite about half of adolescents perceiving the process of FP as difﬁcult,
because of feelings of embarrassment talking about masturbation and
sexual experience.
From an ethical perspective, the child should be involved in the dis-
cussion whenever possible, in order to respect his growing or emerging
autonomy. In our clinical experience, this was done from the age of
5 years onward if their state of health allowed it. We found that from
the age of 7 years, children were able to understand when the language
was adapted and could transcend their fear of undergoing a testicular
biopsy. Another reason for the child’s involvement is that the parental
decision may be complicated by ‘the possible imperative character of
the offer because of the phenomenon of anticipated decision regret’
(ESHRE Task Force on Ethics and Law, 2004), where they fear future
regret of a decision taken at a time of crisis. It is also essential to fully
inform all decision-makers, whether parents or children, whose legal
ability to formally consent to or refuse a treatment varies internationally
with jurisdictions, about possible complications or the lack of evidence
about future use. Last but not least, public information about the avail-
ability of storage will have two ethical beneﬁts: increasing the autono-
mous choice of affected families, and enhancing justice at societal level
to enable fair access to the technique (Tournaye et al., 2014).
While 86.7% of pediatric care providers believe that children of any
age should be included in discussions about FP (Goodwin et al., 2007),
corresponding ﬁgures for parents regarding the involvement of their
........................................................................................
Table V Emotional state of parents during discussion
of FP.
FP
refused
FP
accepted
P-value
General
Satisfactory 11 42 0.40
Too much information at once 3 13
Overwhelmed by child’s diagnosis 3 3
Not a priority: child’s health
comes ﬁrst
2 1
Anxiety
Present 13 27 0.12
Absent 6 32
Self-reported feelings
Pressure from doctor to reduce
delay before cancer treatment
9 1 ,0.01
Hope for future parenthood 4 50 ,0.01
Other (avoiding additional
procedures, child’s health
ﬁrst, etc.)
6 8 0.09
Data are from n ¼ 78 questionnaires.
A comparison was made between accepted or refused FP. The chi-square test was
applied to compare emotional state (anxiety present or not). Fisher’s exact test was
applied for emotional state (satisfactory or not) and for each self-reported feeling.
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children in the decisional process are not yet available. Our survey
showed that .90% of parents considered their child above 12 years of
age able to participate in the decisional process. However, only a
quarter of prepubertal boys aged 7 years or more were considered
mature enough to participate when the language was adapted. Interest-
ingly, this proportion is in line with an identical proportion of children
who felt anxious, mainly about their future fertility.
The quality of fertility counseling provided at the time of cancer diag-
nosis has been identiﬁed as a determining factor in the decision-making
process (Schover et al., 2002a; Achille et al., 2006). This was especially
evident in adolescents, who consider their participation in the decisional
process as important (Quinn et al., 2011) and who must face the chal-
lenge of evaluating their future situation and potential fatherhood
(Chapple et al., 2007). Furthermore, information and communication
are key elements when it comes to legal consent, requiring the individual
to understand the information given, its personal relevance, and then
retain and use it to make an informed choice. This may be very difﬁcult
in any circumstance, but even more so in a pediatric population.
Our survey highlights a number of decisional factors concerning the
quality of communication and content of information provided, which
may help care providers to optimize FP clinical pathways. Among
them, the completeness of information given to patients and parents
appeared to be crucial for FP acceptance. Hence, increasing knowledge
of the care team and providing sufﬁcient human resources to adequately
accompany the patientsmust become a priority. Since information tools
were shown to reduce decisional conﬂict in patients (Huyghe et al.,
2009), development of educational material adapted to the pediatric
population may be of great help in facilitating open communication.
In our study, information was provided in the course of a face-to-face
discussion, mainly by physicians and rarely (2.5% of cases) by nurses. Al-
though nurse supportwas limited in this study, it appeared to be relevant
for 16.6% of adolescents. However, because oncology nurses are in a
prime contact position (Nagel and Neal, 2008), their cooperation
should be sought when trying to optimize FP pathways. Indeed, most
specialist nurses perceived such discussion to be well within their
scope of practice, and only a minority (6%) felt this was an issue that
should only be discussed with physicians (Vadaparampil et al., 2007).
However, as knowledge of nurses was somewhat inadequate (Nagel
and Neal, 2008), providing them with adapted educational tools is im-
perative.
Furthermore, our study showed family support to bemore important
than that of doctors, by contrast with studies in an adult population
where the physician’s support was considered most important (Eiser
et al., 2011). This underlines different needs to be taken into account
when optimizing FP pathways in a pediatric population.
Hope for future parenthood emerged as another positive decisional
factor for FP acceptance. Indeed, besides their children’s potential
future parenthood being an important concern for parents (Van den
Berg et al., 2007), the fact of discussing FP served to place the focus
ﬁrmly on the future and procure a more positive outlook on survival
(Achille et al., 2006). It also provided reassurance that the aim of treat-
ment is cure (Wallace and Thomson, 2003; Wallace et al., 2005),
thereby improving the quality of life at an already stressful time.
By contrast, pressure from doctors to reduce the time interval before
cancer treatment had a negative impact on FP acceptance. Fear that
banking may delay life-saving treatment is already known to be a
reason to refuse FP in a cancer population (Schover et al., 1999). The
role of oncologists is paramount, since patients appear to follow recom-
mendations on FP in the same way as any other aspects of their cancer
treatment (Eiser et al., 2011). An optimal MCCP needs to give oncolo-
gists scope to ensure that FP is carried out without delaying the overall
treatment plan. Close collaboration between oncologists and fertility
specialists is, therefore, essential to protect the needs of cancer patients.
Since the aim of an optimized MCCP is to resolve a huge patient/
parent and physician dilemma, potential involvement of a psychiatrist
or psychologist familiarwith infertility issuesmaybe considered essential.
Liaison psychiatry/counseling consultations allowing a more holistic
approach to treating pediatric cancer patients and guiding discussions
may have a huge impact on their future quality of life.
Limitations
In addition to the fact that this single-center survey fromBelgiumdoesnot
allow extrapolation of gathered information to other settings, a number
of other limitations call for caution. One key issue is linked to the time
interval between the actual FP procedure and the survey that relates
to the so-called recall bias. The non-response error is another potential
source of bias that is hard to quantify. Thequestion is indeedwhether the
people who did not answer are different in any meaningful way from
those who did. While the conﬁdence interval or margin of error for
the parents’ responses was acceptable considering that the study was
retrospective on a 10-year basis, it was slightly higher than the tradition-
ally accepted 5–8% margin of error for the children’s responses. This
could, however, be explained by the fact that the majority (73%) of the
patients are prepubertal boys.
Furthermore, because of the unavailability of preexisting validated
questionnaires or gold standard adapted to this particular topic,
further external validation is required. The obtained data could not be
compared with an existing ‘gold standard’ and hence an extrapolation
cannot be made.
Eventually, perceptions of patients and their parents may be altered
based on whether the method of FP was successful or not. Due to the
unavailability of techniques allowing fertility restoration from ITT cryo-
preservation andhence their success,wecould not exclude this potential
bias from our data analysis.
Conclusion
As the technology for effective FP methods in the pediatric population
continues to improve at a rapid pace, understanding the factors that
may affect their clinical application is vital for practitioners. Acknowledg-
ing issues that patients and parents face and familiarizing oneself with the
needs of those undergoing fertility-threatening therapies give primary
care providers indispensable quality management tools in the ﬁeld of FP.
Reported expectations and feelings should be considered and used to
improve the MCCP design and provide appropriate support for patients
and parents.
Thus, discussions about FP should aim to provide full and understand-
able information andplace the emphasis on the future as positivedecisio-
nal factors. MCCP should accommodate sufﬁcient resources to mitigate
time pressure from oncologists and offer appropriate nurse and liaison
pedopsychiatry/counseling support to enhance patient and parent
quality of life at the time of diagnosis. This also points to the perennial
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issue of equity of access for patients to preventive measures, which are
not always given the same priority as acute medicine.
Larger multicentric studies are nowwarranted on the quality of inter-
ventions in children and adolescents facing fertility-threatening therapies,
in order to provide appropriate information, education and support to
patients, parents and care providers alike.
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